510(K) CLEARANCES 84 ▲14RECALLS POSTED 39 ▲27CLASS I 6 ▲2PMA DECISIONS 47 ▲11WEEK ENDING / FDA DATA AS OF
Medical Device
ManufacturingTHE TRADE PAPER OF THE FACTORY FLOOR
SUBSCRIBE / SIGN IN
K953160Substantially Equivalent

Opus T3

Behring Diagnostics, Inc., Westwood MA / Traditional, Substantially Equivalent
FDA source (opens on fda.gov)

K953160 is the FDA 510(k) clearance record for OPUS T3, a class II device, cleared for Behring Diagnostics, Inc. on under FDA product code CDP (Radioimmunoassay, Total Triiodothyronine). FDA records list 145 510(k) clearances for Behring Diagnostics, Inc., from to . As of , FDA records show no recalls naming K953160.

Clearance record

Decision date
Received
(48 days to decision)
Product code
CDP Radioimmunoassay, Total Triiodothyronine
Regulation
21 CFR 862.1710
Device class
Class II
Review panel
Clinical Chemistry
Applicant
Behring Diagnostics, Inc. 151 University Ave., Westwood MA
510(k) summary
Summary
Third party review
No

Clearances, product code CDP

Trailing 12 months

FDA records hold no clearances under product code CDP in the trailing twelve months.

FDA records show no clearances under product code CDP in the twelve months to October 2026.
Show the numbers
Monthly 510(k) clearances under FDA product code CDP, trailing twelve months
MonthClearances
November 20250
December 20250
January 20260
February 20260
March 20260
April 20260
May 20260
June 20260
July 20260
August 20260
September 20260
October 20260